What's in ABX advanced biochemical compounds GmbH's pipeline?

ABX advanced biochemical compounds GmbH has 2 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with ABX advanced biochemical compounds GmbH's portfolio?

Top competitors by shared drug class: Central Hospital, Nancy, France, Centre hospitalier de l'Université de Montréal (CHUM), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Institute for Neurodegenerative Disorders, OHSU Knight Cancer Institute.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/abx-advanced-biochemical-compounds-gmbh.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

ABX advanced biochemical compounds GmbH — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

ABX advanced biochemical compounds GmbH pipeline: 0 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
F-18-Fluorocholine	F-18-Fluorocholine	phase 3	PET imaging agent	Choline transporters; Choline kinase	Oncology
F-18-PSMA-1007	F-18-PSMA-1007	phase 3	Radiopharmaceutical; PSMA-targeting PET imaging agent	PSMA (prostate-specific membrane antigen)	Oncology

Therapeutic area mix

Oncology · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Central Hospital, Nancy, France · 1 shared drug class
Centre hospitalier de l'Université de Montréal (CHUM) · 1 shared drug class
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · 1 shared drug class
Institute for Neurodegenerative Disorders · 1 shared drug class
OHSU Knight Cancer Institute · 1 shared drug class
Piramal Imaging Limited · 1 shared drug class
SOFIE · 1 shared drug class
Universidad Central del Caribe · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for ABX advanced biochemical compounds GmbH:

Cite this brief

Drug Landscape (2026). ABX advanced biochemical compounds GmbH — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/abx-advanced-biochemical-compounds-gmbh. Accessed 2026-05-17.